

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | endothelial cell chemotaxis (GO:0035767) | 5.55825082 |
| 2 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 4.28212936 |
| 3 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 4.28212936 |
| 4 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 4.24890524 |
| 5 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 4.24890524 |
| 6 | lymph vessel development (GO:0001945) | 3.95959777 |
| 7 | presynaptic membrane assembly (GO:0097105) | 3.74197616 |
| 8 | facial nerve structural organization (GO:0021612) | 3.73718314 |
| 9 | epithelial cell fate commitment (GO:0072148) | 3.71681818 |
| 10 | auditory receptor cell differentiation (GO:0042491) | 3.69936288 |
| 11 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.68793382 |
| 12 | presynaptic membrane organization (GO:0097090) | 3.44453796 |
| 13 | positive regulation of mRNA catabolic process (GO:0061014) | 3.42070544 |
| 14 | lactate metabolic process (GO:0006089) | 3.41937985 |
| 15 | nonmotile primary cilium assembly (GO:0035058) | 3.40369219 |
| 16 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.31232045 |
| 17 | dendritic spine morphogenesis (GO:0060997) | 3.29807654 |
| 18 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.29543470 |
| 19 | lung lobe morphogenesis (GO:0060463) | 3.24918888 |
| 20 | response to gravity (GO:0009629) | 3.23203689 |
| 21 | dentate gyrus development (GO:0021542) | 3.18009679 |
| 22 | photoreceptor cell differentiation (GO:0046530) | 3.17971412 |
| 23 | eye photoreceptor cell differentiation (GO:0001754) | 3.17971412 |
| 24 | microglial cell activation (GO:0001774) | 3.17264191 |
| 25 | endocrine pancreas development (GO:0031018) | 3.13673814 |
| 26 | SMAD protein signal transduction (GO:0060395) | 3.08475000 |
| 27 | response to progesterone (GO:0032570) | 3.08424733 |
| 28 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.07494426 |
| 29 | response to corticosterone (GO:0051412) | 3.05140952 |
| 30 | fibroblast migration (GO:0010761) | 3.03865512 |
| 31 | regulation of mRNA catabolic process (GO:0061013) | 3.01393095 |
| 32 | neuron fate determination (GO:0048664) | 3.00538617 |
| 33 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.98142672 |
| 34 | startle response (GO:0001964) | 2.96460526 |
| 35 | astrocyte differentiation (GO:0048708) | 2.95639264 |
| 36 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.94388474 |
| 37 | positive regulation of calcium ion import (GO:0090280) | 2.94016708 |
| 38 | positive regulation of glycolytic process (GO:0045821) | 2.90936686 |
| 39 | blood vessel maturation (GO:0001955) | 2.89302776 |
| 40 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.89068601 |
| 41 | ER overload response (GO:0006983) | 2.88224822 |
| 42 | RNA destabilization (GO:0050779) | 2.87038144 |
| 43 | ovulation from ovarian follicle (GO:0001542) | 2.84773680 |
| 44 | * cellular response to gonadotropin stimulus (GO:0071371) | 2.84582317 |
| 45 | regulation of neurotransmitter uptake (GO:0051580) | 2.83395513 |
| 46 | negative regulation of complement activation (GO:0045916) | 2.82172253 |
| 47 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.81292110 |
| 48 | nodal signaling pathway (GO:0038092) | 2.80300512 |
| 49 | cranial nerve structural organization (GO:0021604) | 2.79120649 |
| 50 | chondroitin sulfate catabolic process (GO:0030207) | 2.77621956 |
| 51 | regulation of male gonad development (GO:2000018) | 2.77597131 |
| 52 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.75350245 |
| 53 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.75350245 |
| 54 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.75350245 |
| 55 | response to mineralocorticoid (GO:0051385) | 2.73964384 |
| 56 | inner ear receptor stereocilium organization (GO:0060122) | 2.73546767 |
| 57 | blood vessel endothelial cell migration (GO:0043534) | 2.72465868 |
| 58 | regulation of p38MAPK cascade (GO:1900744) | 2.71919361 |
| 59 | endocardial cushion morphogenesis (GO:0003203) | 2.71385513 |
| 60 | righting reflex (GO:0060013) | 2.70469670 |
| 61 | negative regulation of protein autophosphorylation (GO:0031953) | 2.69794454 |
| 62 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.69405040 |
| 63 | positive regulation of mRNA 3-end processing (GO:0031442) | 2.69114616 |
| 64 | * skeletal muscle cell differentiation (GO:0035914) | 2.67797390 |
| 65 | nephron tubule formation (GO:0072079) | 2.66487602 |
| 66 | white fat cell differentiation (GO:0050872) | 2.64760537 |
| 67 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.64227829 |
| 68 | gland morphogenesis (GO:0022612) | 2.62587229 |
| 69 | glomerulus development (GO:0032835) | 2.62065242 |
| 70 | cellular ketone body metabolic process (GO:0046950) | 2.61313206 |
| 71 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.61015787 |
| 72 | atrioventricular valve morphogenesis (GO:0003181) | 2.60753473 |
| 73 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.59118679 |
| 74 | positive regulation of p38MAPK cascade (GO:1900745) | 2.58811006 |
| 75 | brain morphogenesis (GO:0048854) | 2.58128364 |
| 76 | positive regulation of astrocyte differentiation (GO:0048711) | 2.56279826 |
| 77 | prostate gland growth (GO:0060736) | 2.55626762 |
| 78 | mesenchyme morphogenesis (GO:0072132) | 2.54591473 |
| 79 | positive regulation of insulin secretion (GO:0032024) | 2.54302043 |
| 80 | lung vasculature development (GO:0060426) | 2.54257761 |
| 81 | axoneme assembly (GO:0035082) | 2.53318067 |
| 82 | insulin secretion (GO:0030073) | 2.51712499 |
| 83 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.51529745 |
| 84 | parental behavior (GO:0060746) | 2.51055008 |
| 85 | cell differentiation involved in metanephros development (GO:0072202) | 2.50471216 |
| 86 | negative regulation of myoblast differentiation (GO:0045662) | 2.47344521 |
| 87 | renal tubule morphogenesis (GO:0061333) | 2.47165958 |
| 88 | smooth muscle tissue development (GO:0048745) | 2.46523581 |
| 89 | otic vesicle formation (GO:0030916) | 2.46300240 |
| 90 | pharyngeal system development (GO:0060037) | 2.45263711 |
| 91 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.44936319 |
| 92 | negative regulation of gluconeogenesis (GO:0045721) | 2.44255274 |
| 93 | metanephric nephron tubule development (GO:0072234) | 2.43491434 |
| 94 | metanephric tubule development (GO:0072170) | 2.43491434 |
| 95 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.43346391 |
| 96 | reflex (GO:0060004) | 2.42398774 |
| 97 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.41765348 |
| 98 | negative regulation of protein activation cascade (GO:2000258) | 2.41417329 |
| 99 | regulation of hexokinase activity (GO:1903299) | 2.40636436 |
| 100 | regulation of glucokinase activity (GO:0033131) | 2.40636436 |
| 101 | auditory receptor cell stereocilium organization (GO:0060088) | 2.39477025 |
| 102 | dermatan sulfate metabolic process (GO:0030205) | 2.39015040 |
| 103 | endoderm formation (GO:0001706) | 2.38632109 |
| 104 | face morphogenesis (GO:0060325) | 2.38508730 |
| 105 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.38287660 |
| 106 | fucose catabolic process (GO:0019317) | 2.37083952 |
| 107 | L-fucose metabolic process (GO:0042354) | 2.37083952 |
| 108 | L-fucose catabolic process (GO:0042355) | 2.37083952 |
| 109 | peripheral nervous system development (GO:0007422) | 2.36205917 |
| 110 | nephron epithelium morphogenesis (GO:0072088) | 2.36189629 |
| 111 | nephron tubule morphogenesis (GO:0072078) | 2.36189629 |
| 112 | keratinocyte development (GO:0003334) | 2.35258110 |
| 113 | glycerophospholipid catabolic process (GO:0046475) | 2.35034660 |
| 114 | protein K11-linked deubiquitination (GO:0035871) | 2.34956649 |
| 115 | oxygen transport (GO:0015671) | 2.34785056 |
| 116 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.34210470 |
| 117 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.34210470 |
| 118 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.33454863 |
| 119 | cellular response to calcium ion (GO:0071277) | 2.32185400 |
| 120 | mesenchymal cell differentiation (GO:0048762) | 2.30892895 |
| 121 | anatomical structure arrangement (GO:0048532) | 2.29615988 |
| 122 | regulation of mRNA 3-end processing (GO:0031440) | 2.29371854 |
| 123 | male sex determination (GO:0030238) | 2.29208848 |
| 124 | platelet dense granule organization (GO:0060155) | 2.28465961 |
| 125 | sex determination (GO:0007530) | 2.28378715 |
| 126 | photoreceptor cell maintenance (GO:0045494) | 2.27904013 |
| 127 | cyclic nucleotide catabolic process (GO:0009214) | 2.26971952 |
| 128 | response to laminar fluid shear stress (GO:0034616) | 2.26702013 |
| 129 | limb bud formation (GO:0060174) | 2.25766753 |
| 130 | toxin transport (GO:1901998) | 2.24667290 |
| 131 | lymphangiogenesis (GO:0001946) | 2.24553019 |
| 132 | type B pancreatic cell development (GO:0003323) | 2.24326285 |
| 133 | inositol phosphate catabolic process (GO:0071545) | 2.23873639 |
| 134 | positive regulation of glycogen metabolic process (GO:0070875) | 2.23691174 |
| 135 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.23406849 |
| 136 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.23218550 |
| 137 | ketone body metabolic process (GO:1902224) | 2.23033705 |
| 138 | * response to gonadotropin (GO:0034698) | 2.23014760 |
| 139 | cAMP catabolic process (GO:0006198) | 2.22622553 |
| 140 | radial glial cell differentiation (GO:0060019) | 2.22250462 |
| 141 | venous blood vessel morphogenesis (GO:0048845) | 2.22011127 |
| 142 | regulation of cilium movement (GO:0003352) | 2.20918953 |
| 143 | regulation of monocyte differentiation (GO:0045655) | 2.19945432 |
| 144 | positive regulation of peptide hormone secretion (GO:0090277) | 2.19632990 |
| 145 | Sertoli cell development (GO:0060009) | 2.19274825 |
| 146 | nitric oxide mediated signal transduction (GO:0007263) | 2.18925187 |
| 147 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.17716806 |
| 148 | endothelial cell morphogenesis (GO:0001886) | 2.17142707 |
| 149 | viral protein processing (GO:0019082) | 2.16620773 |
| 150 | negative regulation of inclusion body assembly (GO:0090084) | 2.16209440 |
| 151 | regulation of gamma-delta T cell activation (GO:0046643) | 2.14435431 |
| 152 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.13250502 |
| 153 | surfactant homeostasis (GO:0043129) | 2.13054296 |
| 154 | positive regulation of vasculogenesis (GO:2001214) | 2.12993121 |
| 155 | mitotic cell cycle arrest (GO:0071850) | 2.12964315 |
| 156 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.11671514 |
| 157 | macrophage activation (GO:0042116) | 2.11490596 |
| 158 | positive regulation of mRNA processing (GO:0050685) | 2.11002163 |
| 159 | endothelium development (GO:0003158) | 2.10687778 |
| 160 | heart valve morphogenesis (GO:0003179) | 2.10261484 |
| 161 | sleep (GO:0030431) | 2.10096236 |
| 162 | * regulation of cell proliferation involved in kidney development (GO:1901722) | 2.09395819 |
| 163 | cellular response to fluid shear stress (GO:0071498) | 2.09336384 |
| 164 | definitive hemopoiesis (GO:0060216) | 2.08924760 |
| 165 | trophoblast giant cell differentiation (GO:0060707) | 2.08881265 |
| 166 | protein heterotrimerization (GO:0070208) | 2.08526173 |
| 167 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.08047823 |
| 168 | negative regulation of smooth muscle contraction (GO:0045986) | 2.06972632 |
| 169 | mesodermal cell differentiation (GO:0048333) | 2.06302466 |
| 170 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.06087375 |
| 171 | response to fluid shear stress (GO:0034405) | 2.05057902 |
| 172 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.03718425 |
| 173 | regulation of somitogenesis (GO:0014807) | 2.01643900 |
| 174 | negative regulation of norepinephrine secretion (GO:0010700) | 2.00796799 |
| 175 | metanephric mesenchyme development (GO:0072075) | 2.00767181 |
| 176 | monocyte differentiation (GO:0030224) | 2.00699442 |
| 177 | peripheral nervous system axon ensheathment (GO:0032292) | 2.00536787 |
| 178 | myelination in peripheral nervous system (GO:0022011) | 2.00536787 |
| 179 | gas transport (GO:0015669) | 1.99256881 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.38202604 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.22253602 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.31020329 |
| 4 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.29928764 |
| 5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.28191119 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.23123465 |
| 7 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.22446926 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.16835795 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.14551469 |
| 10 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.11107444 |
| 11 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.05519276 |
| 12 | * TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.00201370 |
| 13 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.99056237 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.93298236 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.90526546 |
| 16 | FUS_26573619_Chip-Seq_HEK293_Human | 1.90339613 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.90089535 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.89686643 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.88860351 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.87473974 |
| 21 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.85961176 |
| 22 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.85666210 |
| 23 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.83722502 |
| 24 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.83400619 |
| 25 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.78448806 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.76536565 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.74131459 |
| 28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.74131459 |
| 29 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.71656231 |
| 30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.69087548 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.68322680 |
| 32 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.61598822 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.59960417 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.59102854 |
| 35 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.58323315 |
| 36 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.57389727 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.56046838 |
| 38 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.55186156 |
| 39 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.54404007 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.54035300 |
| 41 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.53394949 |
| 42 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.52035645 |
| 43 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.51725894 |
| 44 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.51725894 |
| 45 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.51725894 |
| 46 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.51168591 |
| 47 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.51097622 |
| 48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.50322038 |
| 49 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.50157544 |
| 50 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.49865368 |
| 51 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.49190376 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.49074114 |
| 53 | CJUN_26792858_Chip-Seq_BT549_Human | 1.48155159 |
| 54 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.47479223 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.47047195 |
| 56 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.44861434 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.44295440 |
| 58 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.43897607 |
| 59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.41961119 |
| 60 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.41533294 |
| 61 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.41502298 |
| 62 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39716836 |
| 63 | TP53_16413492_ChIP-PET_HCT116_Human | 1.38375014 |
| 64 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.38159313 |
| 65 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36724494 |
| 66 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.35814374 |
| 67 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.35767991 |
| 68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.35001705 |
| 69 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.34543049 |
| 70 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.34029239 |
| 71 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34029239 |
| 72 | EWS_26573619_Chip-Seq_HEK293_Human | 1.33169882 |
| 73 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32408043 |
| 74 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.30775045 |
| 75 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.30505427 |
| 76 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.28906754 |
| 77 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.27710172 |
| 78 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.26721782 |
| 79 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.23575639 |
| 80 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.22727430 |
| 81 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.21259764 |
| 82 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20245367 |
| 83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19968293 |
| 84 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19968293 |
| 85 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.18493289 |
| 86 | TCF4_23295773_ChIP-Seq_U87_Human | 1.18405265 |
| 87 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.18096523 |
| 88 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17390781 |
| 89 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17390781 |
| 90 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17155697 |
| 91 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17125843 |
| 92 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16952388 |
| 93 | P300_19829295_ChIP-Seq_ESCs_Human | 1.14547079 |
| 94 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.13892764 |
| 95 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13691378 |
| 96 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.12684298 |
| 97 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.12282873 |
| 98 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11251283 |
| 99 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.10800010 |
| 100 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.10499529 |
| 101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.10331804 |
| 102 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09368286 |
| 103 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.09020894 |
| 104 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.08492150 |
| 105 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.08454708 |
| 106 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08424410 |
| 107 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08144067 |
| 108 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08065358 |
| 109 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.07766767 |
| 110 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.07672948 |
| 111 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.07501825 |
| 112 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06712392 |
| 113 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.06475180 |
| 114 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.05795314 |
| 115 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05018189 |
| 116 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04286296 |
| 117 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03887419 |
| 118 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03573129 |
| 119 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03303315 |
| 120 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02946157 |
| 121 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02330774 |
| 122 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02033829 |
| 123 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02015576 |
| 124 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01814774 |
| 125 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.01725156 |
| 126 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.01618718 |
| 127 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.01566795 |
| 128 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00284281 |
| 129 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99399138 |
| 130 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.99145980 |
| 131 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.97906020 |
| 132 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97889187 |
| 133 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.97387430 |
| 134 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.96216699 |
| 135 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95625311 |
| 136 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.94282190 |
| 137 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93579606 |
| 138 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93538842 |
| 139 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93397877 |
| 140 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.92911300 |
| 141 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.91997985 |
| 142 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.91605340 |
| 143 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90913916 |
| 144 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.90474214 |
| 145 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90151300 |
| 146 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.89299933 |
| 147 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88867254 |
| 148 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88639708 |
| 149 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.88496360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 3.91811267 |
| 2 | MP0005503_abnormal_tendon_morphology | 3.60044694 |
| 3 | MP0003724_increased_susceptibility_to | 3.43594001 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 2.90547350 |
| 5 | MP0002009_preneoplasia | 2.88384398 |
| 6 | MP0003195_calcinosis | 2.78696844 |
| 7 | MP0006072_abnormal_retinal_apoptosis | 2.62530870 |
| 8 | MP0003828_pulmonary_edema | 2.54105289 |
| 9 | MP0002254_reproductive_system_inflammat | 2.49501108 |
| 10 | MP0003283_abnormal_digestive_organ | 2.46471242 |
| 11 | MP0001879_abnormal_lymphatic_vessel | 2.46372284 |
| 12 | MP0001851_eye_inflammation | 2.42272015 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.36722625 |
| 14 | MP0005275_abnormal_skin_tensile | 2.35848964 |
| 15 | MP0005379_endocrine/exocrine_gland_phen | 2.32752364 |
| 16 | MP0004272_abnormal_basement_membrane | 2.30274763 |
| 17 | MP0003787_abnormal_imprinting | 2.22845145 |
| 18 | MP0004885_abnormal_endolymph | 2.08775306 |
| 19 | MP0001944_abnormal_pancreas_morphology | 2.07290233 |
| 20 | MP0005508_abnormal_skeleton_morphology | 2.05756017 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 2.02370969 |
| 22 | MP0002909_abnormal_adrenal_gland | 2.00630607 |
| 23 | MP0003279_aneurysm | 1.89335886 |
| 24 | MP0003941_abnormal_skin_development | 1.86062184 |
| 25 | MP0000678_abnormal_parathyroid_gland | 1.79882005 |
| 26 | MP0008995_early_reproductive_senescence | 1.79074371 |
| 27 | MP0001984_abnormal_olfaction | 1.77424875 |
| 28 | MP0002163_abnormal_gland_morphology | 1.72888628 |
| 29 | MP0002876_abnormal_thyroid_physiology | 1.72704786 |
| 30 | MP0005187_abnormal_penis_morphology | 1.70928476 |
| 31 | MP0005551_abnormal_eye_electrophysiolog | 1.70097401 |
| 32 | MP0000049_abnormal_middle_ear | 1.69665165 |
| 33 | MP0002108_abnormal_muscle_morphology | 1.69117011 |
| 34 | MP0002877_abnormal_melanocyte_morpholog | 1.67126064 |
| 35 | MP0001346_abnormal_lacrimal_gland | 1.66723079 |
| 36 | MP0003943_abnormal_hepatobiliary_system | 1.65740970 |
| 37 | * MP0000631_abnormal_neuroendocrine_gland | 1.64639115 |
| 38 | MP0000566_synostosis | 1.63913367 |
| 39 | MP0005409_darkened_coat_color | 1.62658992 |
| 40 | MP0005423_abnormal_somatic_nervous | 1.60838129 |
| 41 | MP0004742_abnormal_vestibular_system | 1.60265397 |
| 42 | MP0005253_abnormal_eye_physiology | 1.59934205 |
| 43 | MP0002060_abnormal_skin_morphology | 1.54947076 |
| 44 | MP0005390_skeleton_phenotype | 1.53045483 |
| 45 | MP0009384_cardiac_valve_regurgitation | 1.49972558 |
| 46 | MP0003763_abnormal_thymus_physiology | 1.49237473 |
| 47 | MP0010329_abnormal_lipoprotein_level | 1.47859171 |
| 48 | MP0001188_hyperpigmentation | 1.47855652 |
| 49 | * MP0002557_abnormal_social/conspecific_i | 1.47853767 |
| 50 | MP0000613_abnormal_salivary_gland | 1.47220487 |
| 51 | MP0002938_white_spotting | 1.45788224 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.45721360 |
| 53 | MP0001486_abnormal_startle_reflex | 1.44607277 |
| 54 | MP0002693_abnormal_pancreas_physiology | 1.43891665 |
| 55 | MP0000427_abnormal_hair_cycle | 1.43005328 |
| 56 | MP0010678_abnormal_skin_adnexa | 1.38030972 |
| 57 | MP0009745_abnormal_behavioral_response | 1.36051493 |
| 58 | MP0000538_abnormal_urinary_bladder | 1.35221152 |
| 59 | MP0001756_abnormal_urination | 1.33723738 |
| 60 | MP0002295_abnormal_pulmonary_circulatio | 1.32849250 |
| 61 | MP0009278_abnormal_bone_marrow | 1.32320108 |
| 62 | MP0002933_joint_inflammation | 1.32200289 |
| 63 | MP0000639_abnormal_adrenal_gland | 1.32050401 |
| 64 | MP0002638_abnormal_pupillary_reflex | 1.30458801 |
| 65 | MP0000516_abnormal_urinary_system | 1.30448638 |
| 66 | MP0005367_renal/urinary_system_phenotyp | 1.30448638 |
| 67 | MP0009046_muscle_twitch | 1.30051153 |
| 68 | MP0003122_maternal_imprinting | 1.28094986 |
| 69 | MP0000163_abnormal_cartilage_morphology | 1.27368162 |
| 70 | MP0002896_abnormal_bone_mineralization | 1.27166161 |
| 71 | MP0004133_heterotaxia | 1.26792282 |
| 72 | MP0005084_abnormal_gallbladder_morpholo | 1.25718977 |
| 73 | MP0004381_abnormal_hair_follicle | 1.25510823 |
| 74 | MP0010234_abnormal_vibrissa_follicle | 1.24591551 |
| 75 | MP0005220_abnormal_exocrine_pancreas | 1.22033782 |
| 76 | MP0000767_abnormal_smooth_muscle | 1.21965602 |
| 77 | MP0005248_abnormal_Harderian_gland | 1.21041697 |
| 78 | MP0005171_absent_coat_pigmentation | 1.20693454 |
| 79 | MP0002272_abnormal_nervous_system | 1.19960936 |
| 80 | MP0002928_abnormal_bile_duct | 1.18903002 |
| 81 | MP0004043_abnormal_pH_regulation | 1.18673347 |
| 82 | MP0001502_abnormal_circadian_rhythm | 1.17681137 |
| 83 | MP0009250_abnormal_appendicular_skeleto | 1.16637308 |
| 84 | MP0001533_abnormal_skeleton_physiology | 1.15956374 |
| 85 | MP0005388_respiratory_system_phenotype | 1.14907234 |
| 86 | MP0002133_abnormal_respiratory_system | 1.14907234 |
| 87 | MP0009780_abnormal_chondrocyte_physiolo | 1.13972644 |
| 88 | MP0002249_abnormal_larynx_morphology | 1.13929273 |
| 89 | MP0004510_myositis | 1.12947210 |
| 90 | MP0008961_abnormal_basal_metabolism | 1.12388261 |
| 91 | MP0000647_abnormal_sebaceous_gland | 1.11095063 |
| 92 | MP0003136_yellow_coat_color | 1.10677825 |
| 93 | MP0003300_gastrointestinal_ulcer | 1.10255942 |
| 94 | MP0003045_fibrosis | 1.07829972 |
| 95 | MP0000762_abnormal_tongue_morphology | 1.07158238 |
| 96 | MP0001958_emphysema | 1.06820359 |
| 97 | MP0001485_abnormal_pinna_reflex | 1.05149085 |
| 98 | MP0002089_abnormal_postnatal_growth/wei | 1.04769266 |
| 99 | MP0001542_abnormal_bone_strength | 1.04442803 |
| 100 | MP0000778_abnormal_nervous_system | 1.03602767 |
| 101 | MP0005645_abnormal_hypothalamus_physiol | 1.02589888 |
| 102 | MP0002168_other_aberrant_phenotype | 1.01961028 |
| 103 | MP0005595_abnormal_vascular_smooth | 1.00184844 |
| 104 | * MP0003795_abnormal_bone_structure | 0.99755405 |
| 105 | MP0002116_abnormal_craniofacial_bone | 0.99613798 |
| 106 | * MP0004883_abnormal_blood_vessel | 0.99557319 |
| 107 | * MP0002572_abnormal_emotion/affect_behav | 0.98451454 |
| 108 | MP0001340_abnormal_eyelid_morphology | 0.98142511 |
| 109 | MP0008004_abnormal_stomach_pH | 0.96195283 |
| 110 | MP0000383_abnormal_hair_follicle | 0.96132091 |
| 111 | MP0001270_distended_abdomen | 0.93898537 |
| 112 | * MP0005646_abnormal_pituitary_gland | 0.93642699 |
| 113 | MP0002064_seizures | 0.92871715 |
| 114 | MP0002078_abnormal_glucose_homeostasis | 0.92740256 |
| 115 | MP0004924_abnormal_behavior | 0.92328482 |
| 116 | MP0005386_behavior/neurological_phenoty | 0.92328482 |
| 117 | MP0002138_abnormal_hepatobiliary_system | 0.91999946 |
| 118 | MP0008877_abnormal_DNA_methylation | 0.91828745 |
| 119 | MP0004019_abnormal_vitamin_homeostasis | 0.91804015 |
| 120 | MP0002102_abnormal_ear_morphology | 0.91647660 |
| 121 | MP0005448_abnormal_energy_balance | 0.90937857 |
| 122 | MP0006276_abnormal_autonomic_nervous | 0.90936351 |
| 123 | MP0005165_increased_susceptibility_to | 0.89938243 |
| 124 | MP0002115_abnormal_skeleton_extremities | 0.89044623 |
| 125 | MP0000003_abnormal_adipose_tissue | 0.88966444 |
| 126 | MP0001177_atelectasis | 0.88322100 |
| 127 | MP0009379_abnormal_foot_pigmentation | 0.86584967 |
| 128 | * MP0005164_abnormal_response_to | 0.86288592 |
| 129 | MP0000534_abnormal_ureter_morphology | 0.86226109 |
| 130 | MP0008789_abnormal_olfactory_epithelium | 0.85298262 |
| 131 | MP0002113_abnormal_skeleton_development | 0.85166590 |
| 132 | MP0000026_abnormal_inner_ear | 0.84779813 |
| 133 | MP0004484_altered_response_of | 0.82542290 |
| 134 | MP0003880_abnormal_central_pattern | 0.82435884 |
| 135 | MP0004142_abnormal_muscle_tone | 0.81311837 |
| 136 | MP0004085_abnormal_heartbeat | 0.80882735 |
| 137 | MP0008875_abnormal_xenobiotic_pharmacok | 0.79777950 |
| 138 | MP0002166_altered_tumor_susceptibility | 0.78897956 |
| 139 | MP0004270_analgesia | 0.77832677 |
| 140 | MP0003890_abnormal_embryonic-extraembry | 0.77467706 |
| 141 | MP0005310_abnormal_salivary_gland | 0.77064688 |
| 142 | MP0004147_increased_porphyrin_level | 0.76754554 |
| 143 | * MP0003953_abnormal_hormone_level | 0.75703742 |
| 144 | MP0001853_heart_inflammation | 0.74693908 |
| 145 | MP0002233_abnormal_nose_morphology | 0.74289095 |
| 146 | MP0002277_abnormal_respiratory_mucosa | 0.73753732 |
| 147 | MP0003385_abnormal_body_wall | 0.73173183 |
| 148 | MP0002282_abnormal_trachea_morphology | 0.72997352 |
| 149 | MP0001963_abnormal_hearing_physiology | 0.72870910 |
| 150 | MP0002177_abnormal_outer_ear | 0.72128631 |
| 151 | MP0001970_abnormal_pain_threshold | 0.71854851 |
| 152 | MP0002736_abnormal_nociception_after | 0.71590667 |
| 153 | MP0001968_abnormal_touch/_nociception | 0.70993371 |
| 154 | MP0000013_abnormal_adipose_tissue | 0.70909248 |
| 155 | MP0005257_abnormal_intraocular_pressure | 0.70139706 |
| 156 | MP0002069_abnormal_eating/drinking_beha | 0.69814102 |
| 157 | MP0003633_abnormal_nervous_system | 0.69675439 |
| 158 | MP0003942_abnormal_urinary_system | 0.69465993 |
| 159 | MP0003755_abnormal_palate_morphology | 0.69460375 |
| 160 | MP0005365_abnormal_bile_salt | 0.69441124 |
| 161 | MP0006292_abnormal_olfactory_placode | 0.69391422 |
| 162 | MP0001790_abnormal_immune_system | 0.69146889 |
| 163 | MP0005387_immune_system_phenotype | 0.69146889 |
| 164 | MP0002109_abnormal_limb_morphology | 0.68305458 |
| 165 | MP0003453_abnormal_keratinocyte_physiol | 0.67867348 |
| 166 | MP0010386_abnormal_urinary_bladder | 0.67455062 |
| 167 | MP0000470_abnormal_stomach_morphology | 0.67439063 |
| 168 | MP0004782_abnormal_surfactant_physiolog | 0.67034549 |
| 169 | MP0002932_abnormal_joint_morphology | 0.66859362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomach cancer (HP:0012126) | 4.70594174 |
| 2 | Ulnar claw (HP:0001178) | 4.68531488 |
| 3 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.92783199 |
| 4 | Upper limb muscle weakness (HP:0003484) | 3.83078965 |
| 5 | Vascular tortuosity (HP:0004948) | 3.57068945 |
| 6 | Hemiparesis (HP:0001269) | 3.55145820 |
| 7 | Peripheral hypomyelination (HP:0007182) | 3.41881376 |
| 8 | Large for gestational age (HP:0001520) | 3.36828054 |
| 9 | Arterial tortuosity (HP:0005116) | 3.30792541 |
| 10 | Hypothermia (HP:0002045) | 3.21797786 |
| 11 | Abnormal sex determination (HP:0012244) | 3.21065710 |
| 12 | Sex reversal (HP:0012245) | 3.21065710 |
| 13 | Intestinal atresia (HP:0011100) | 3.09541929 |
| 14 | Hyperglycemia (HP:0003074) | 3.09497182 |
| 15 | Prostate neoplasm (HP:0100787) | 3.09049217 |
| 16 | Broad metatarsal (HP:0001783) | 3.07686664 |
| 17 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.02328020 |
| 18 | Pancreatic cysts (HP:0001737) | 3.00714580 |
| 19 | Congenital sensorineural hearing impairment (HP:0008527) | 2.96767896 |
| 20 | Hyperventilation (HP:0002883) | 2.94219305 |
| 21 | Hypoglycemic seizures (HP:0002173) | 2.92892272 |
| 22 | Pancreatic fibrosis (HP:0100732) | 2.89557102 |
| 23 | Obstructive sleep apnea (HP:0002870) | 2.89489493 |
| 24 | Medial flaring of the eyebrow (HP:0010747) | 2.73354369 |
| 25 | Abnormality of the metopic suture (HP:0005556) | 2.67952629 |
| 26 | Ketoacidosis (HP:0001993) | 2.65823343 |
| 27 | Enlarged penis (HP:0000040) | 2.65487434 |
| 28 | Abnormality of the nasal septum (HP:0000419) | 2.64059665 |
| 29 | Lip pit (HP:0100267) | 2.63290056 |
| 30 | Aqueductal stenosis (HP:0002410) | 2.62320693 |
| 31 | Bone cyst (HP:0012062) | 2.54549115 |
| 32 | Cystic liver disease (HP:0006706) | 2.52890056 |
| 33 | Abnormality of incisor morphology (HP:0011063) | 2.51043054 |
| 34 | Alveolar cell carcinoma (HP:0006519) | 2.50454086 |
| 35 | Hypoglycemic coma (HP:0001325) | 2.49682865 |
| 36 | Aortic aneurysm (HP:0004942) | 2.47876853 |
| 37 | Cervical subluxation (HP:0003308) | 2.47524203 |
| 38 | Aortic valve stenosis (HP:0001650) | 2.42697479 |
| 39 | Abnormality of the renal cortex (HP:0011035) | 2.39667026 |
| 40 | Nephronophthisis (HP:0000090) | 2.37696952 |
| 41 | Submucous cleft hard palate (HP:0000176) | 2.36096254 |
| 42 | EEG with generalized epileptiform discharges (HP:0011198) | 2.35465451 |
| 43 | Abnormality of the renal medulla (HP:0100957) | 2.34481371 |
| 44 | J-shaped sella turcica (HP:0002680) | 2.32223138 |
| 45 | Hypsarrhythmia (HP:0002521) | 2.31401735 |
| 46 | Tubular atrophy (HP:0000092) | 2.31356124 |
| 47 | Pulmonary artery stenosis (HP:0004415) | 2.29853494 |
| 48 | Abnormality of the labia minora (HP:0012880) | 2.29386258 |
| 49 | Follicular hyperkeratosis (HP:0007502) | 2.29261237 |
| 50 | Congenital primary aphakia (HP:0007707) | 2.29185984 |
| 51 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.28287012 |
| 52 | Gait imbalance (HP:0002141) | 2.27823889 |
| 53 | Epileptiform EEG discharges (HP:0011182) | 2.25799713 |
| 54 | Hypoplastic labia majora (HP:0000059) | 2.24703109 |
| 55 | Urethral obstruction (HP:0000796) | 2.21483264 |
| 56 | Aplasia involving bones of the extremities (HP:0009825) | 2.19633619 |
| 57 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.19633619 |
| 58 | Aplasia of the phalanges of the hand (HP:0009802) | 2.19633619 |
| 59 | Labial hypoplasia (HP:0000066) | 2.18413828 |
| 60 | Hypomagnesemia (HP:0002917) | 2.17635783 |
| 61 | Widely spaced teeth (HP:0000687) | 2.17097459 |
| 62 | Abnormality of midbrain morphology (HP:0002418) | 2.16965973 |
| 63 | Molar tooth sign on MRI (HP:0002419) | 2.16965973 |
| 64 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.14805735 |
| 65 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.14805735 |
| 66 | Abnormality of molar (HP:0011077) | 2.13563283 |
| 67 | Abnormality of molar morphology (HP:0011070) | 2.13563283 |
| 68 | Hematochezia (HP:0002573) | 2.13113767 |
| 69 | White forelock (HP:0002211) | 2.12742797 |
| 70 | Cupped ear (HP:0000378) | 2.12341350 |
| 71 | Laryngomalacia (HP:0001601) | 2.12296198 |
| 72 | Epiphyseal dysplasia (HP:0002656) | 2.11944383 |
| 73 | Spondylolisthesis (HP:0003302) | 2.11670653 |
| 74 | Polydipsia (HP:0001959) | 2.09547806 |
| 75 | Abnormal drinking behavior (HP:0030082) | 2.09547806 |
| 76 | Flared iliac wings (HP:0002869) | 2.08707302 |
| 77 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.08210051 |
| 78 | Abnormality of the labia majora (HP:0012881) | 2.08139352 |
| 79 | Absent speech (HP:0001344) | 2.07752572 |
| 80 | Ketosis (HP:0001946) | 2.07508311 |
| 81 | Impaired proprioception (HP:0010831) | 2.05685861 |
| 82 | Median cleft lip (HP:0000161) | 2.04154964 |
| 83 | Gastrointestinal atresia (HP:0002589) | 2.03797372 |
| 84 | Nasolacrimal duct obstruction (HP:0000579) | 2.03197324 |
| 85 | Thickened helices (HP:0000391) | 2.02434368 |
| 86 | Disproportionate tall stature (HP:0001519) | 2.01260531 |
| 87 | Prominent supraorbital ridges (HP:0000336) | 2.00600912 |
| 88 | Hypoplastic female external genitalia (HP:0012815) | 1.99930763 |
| 89 | Aortic dissection (HP:0002647) | 1.99667606 |
| 90 | Nephrogenic diabetes insipidus (HP:0009806) | 1.99625072 |
| 91 | Hepatoblastoma (HP:0002884) | 1.98416701 |
| 92 | Mixed hearing impairment (HP:0000410) | 1.98200113 |
| 93 | Lymphangioma (HP:0100764) | 1.98043361 |
| 94 | Downturned corners of mouth (HP:0002714) | 1.97431536 |
| 95 | Congenital stationary night blindness (HP:0007642) | 1.96364076 |
| 96 | Hamartoma of the eye (HP:0010568) | 1.96109935 |
| 97 | Short hallux (HP:0010109) | 1.95634735 |
| 98 | Optic nerve hypoplasia (HP:0000609) | 1.95009653 |
| 99 | Bell-shaped thorax (HP:0001591) | 1.94993067 |
| 100 | Adrenal hypoplasia (HP:0000835) | 1.94876198 |
| 101 | Corneal dystrophy (HP:0001131) | 1.93334857 |
| 102 | Broad foot (HP:0001769) | 1.92941765 |
| 103 | Patchy hypopigmentation of hair (HP:0011365) | 1.92890138 |
| 104 | Genital tract atresia (HP:0001827) | 1.92851753 |
| 105 | Sleep apnea (HP:0010535) | 1.92473271 |
| 106 | Occipital encephalocele (HP:0002085) | 1.92290247 |
| 107 | Growth hormone excess (HP:0000845) | 1.92200020 |
| 108 | Attenuation of retinal blood vessels (HP:0007843) | 1.91585689 |
| 109 | Increased corneal curvature (HP:0100692) | 1.90720353 |
| 110 | Keratoconus (HP:0000563) | 1.90720353 |
| 111 | Increased CSF protein (HP:0002922) | 1.90029795 |
| 112 | Male pseudohermaphroditism (HP:0000037) | 1.89704054 |
| 113 | Abnormality of the dental root (HP:0006486) | 1.89425209 |
| 114 | Taurodontia (HP:0000679) | 1.89425209 |
| 115 | Abnormality of permanent molar morphology (HP:0011071) | 1.89425209 |
| 116 | Neoplasm of the heart (HP:0100544) | 1.89280504 |
| 117 | Neoplasm of the adrenal cortex (HP:0100641) | 1.88462879 |
| 118 | Hypoplastic iliac wings (HP:0002866) | 1.88338576 |
| 119 | Type II lissencephaly (HP:0007260) | 1.87632115 |
| 120 | Conical tooth (HP:0000698) | 1.85932343 |
| 121 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.85909830 |
| 122 | Atrophic scars (HP:0001075) | 1.84195249 |
| 123 | Onion bulb formation (HP:0003383) | 1.84125156 |
| 124 | Congenital malformation of the right heart (HP:0011723) | 1.83671249 |
| 125 | Double outlet right ventricle (HP:0001719) | 1.83671249 |
| 126 | Distal lower limb muscle weakness (HP:0009053) | 1.83510946 |
| 127 | Furrowed tongue (HP:0000221) | 1.80837404 |
| 128 | Prominent metopic ridge (HP:0005487) | 1.80717488 |
| 129 | Fibular hypoplasia (HP:0003038) | 1.80593600 |
| 130 | Steppage gait (HP:0003376) | 1.80173017 |
| 131 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.79395453 |
| 132 | Abnormality of the nasolacrimal system (HP:0000614) | 1.78234989 |
| 133 | Postaxial hand polydactyly (HP:0001162) | 1.77863734 |
| 134 | Abnormality of the dental pulp (HP:0006479) | 1.77828485 |
| 135 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.76965280 |
| 136 | Milia (HP:0001056) | 1.76654023 |
| 137 | Synostosis involving the elbow (HP:0003938) | 1.76270100 |
| 138 | Humeroradial synostosis (HP:0003041) | 1.76270100 |
| 139 | Bulbous nose (HP:0000414) | 1.75867903 |
| 140 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.75603071 |
| 141 | Scrotal hypoplasia (HP:0000046) | 1.75448003 |
| 142 | Gaze-evoked nystagmus (HP:0000640) | 1.74893078 |
| 143 | Short metatarsal (HP:0010743) | 1.74801081 |
| 144 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.73443390 |
| 145 | Vaginal atresia (HP:0000148) | 1.73285170 |
| 146 | Hypoplastic ischia (HP:0003175) | 1.72835487 |
| 147 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.72759092 |
| 148 | Short 4th metacarpal (HP:0010044) | 1.72759092 |
| 149 | Accelerated skeletal maturation (HP:0005616) | 1.72067507 |
| 150 | Albinism (HP:0001022) | 1.71455372 |
| 151 | Broad face (HP:0000283) | 1.70539783 |
| 152 | Abnormality of the ischium (HP:0003174) | 1.70293163 |
| 153 | Abnormality of the labia (HP:0000058) | 1.70232005 |
| 154 | Hypoplasia of the odontoid process (HP:0003311) | 1.69615430 |
| 155 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.69378418 |
| 156 | Dysostosis multiplex (HP:0000943) | 1.69135933 |
| 157 | Cranial hyperostosis (HP:0004437) | 1.68879678 |
| 158 | Bronchomalacia (HP:0002780) | 1.68580912 |
| 159 | Abnormality of the lacrimal duct (HP:0011481) | 1.68532348 |
| 160 | Abnormal ciliary motility (HP:0012262) | 1.68370627 |
| 161 | Premature rupture of membranes (HP:0001788) | 1.68349835 |
| 162 | Febrile seizures (HP:0002373) | 1.68234305 |
| 163 | Cerebral aneurysm (HP:0004944) | 1.68145347 |
| 164 | Progressive cerebellar ataxia (HP:0002073) | 1.67903873 |
| 165 | Abnormality of vitamin B metabolism (HP:0004340) | 1.67833938 |
| 166 | Disproportionate short-trunk short stature (HP:0003521) | 1.67322280 |
| 167 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.66249870 |
| 168 | Abnormality of the femoral head (HP:0003368) | 1.63810504 |
| 169 | Spontaneous hematomas (HP:0007420) | 1.63248861 |
| 170 | Craniofacial hyperostosis (HP:0004493) | 1.62868689 |
| 171 | True hermaphroditism (HP:0010459) | 1.61939458 |
| 172 | Flat capital femoral epiphysis (HP:0003370) | 1.61093069 |
| 173 | Neonatal short-limb short stature (HP:0008921) | 1.60833308 |
| 174 | Premature skin wrinkling (HP:0100678) | 1.59828426 |
| 175 | Abnormality of the fovea (HP:0000493) | 1.57936531 |
| 176 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.57575414 |
| 177 | Joint stiffness (HP:0001387) | 1.57471195 |
| 178 | Nephropathy (HP:0000112) | 1.57369172 |
| 179 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.56638903 |
| 180 | Hypoplasia of the fovea (HP:0007750) | 1.56638903 |
| 181 | Aplasia cutis congenita (HP:0001057) | 1.55011093 |
| 182 | Shallow orbits (HP:0000586) | 1.54713205 |
| 183 | Hypoplasia of the iris (HP:0007676) | 1.53737865 |
| 184 | Xerostomia (HP:0000217) | 1.53480164 |
| 185 | Bifid scrotum (HP:0000048) | 1.53122814 |
| 186 | Down-sloping shoulders (HP:0200021) | 1.50854115 |
| 187 | Asymmetry of the thorax (HP:0001555) | 1.50804143 |
| 188 | Full cheeks (HP:0000293) | 1.48796219 |
| 189 | Systemic lupus erythematosus (HP:0002725) | 1.48769286 |
| 190 | Abnormality of the odontoid process (HP:0003310) | 1.47907544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 7.16696275 |
| 2 | TGFBR2 | 3.72673207 |
| 3 | TIE1 | 3.24926768 |
| 4 | MAP2K2 | 2.73156821 |
| 5 | MAP4K2 | 2.44328477 |
| 6 | PNCK | 2.39234061 |
| 7 | MAPK7 | 2.05983945 |
| 8 | PIM2 | 2.00480176 |
| 9 | VRK1 | 1.92331013 |
| 10 | BMPR2 | 1.88312131 |
| 11 | GRK7 | 1.85849814 |
| 12 | STK38L | 1.76649023 |
| 13 | NLK | 1.76131504 |
| 14 | MAPKAPK5 | 1.75420228 |
| 15 | MAP3K14 | 1.71985848 |
| 16 | TNIK | 1.66602928 |
| 17 | WEE1 | 1.65683109 |
| 18 | EPHB1 | 1.63350767 |
| 19 | NEK6 | 1.62270977 |
| 20 | INSRR | 1.59071032 |
| 21 | EPHA3 | 1.57036043 |
| 22 | TXK | 1.56583888 |
| 23 | BMPR1B | 1.54607316 |
| 24 | CDK3 | 1.52135106 |
| 25 | IKBKB | 1.45550558 |
| 26 | MAP3K3 | 1.36397840 |
| 27 | HIPK2 | 1.35708460 |
| 28 | STK39 | 1.34162201 |
| 29 | BRSK2 | 1.33115207 |
| 30 | CASK | 1.29139487 |
| 31 | WNK3 | 1.28764402 |
| 32 | PHKG1 | 1.28149088 |
| 33 | PHKG2 | 1.28149088 |
| 34 | CHUK | 1.25815027 |
| 35 | IKBKE | 1.18257977 |
| 36 | SIK3 | 1.15084381 |
| 37 | DMPK | 1.14515359 |
| 38 | PRKD3 | 1.13893844 |
| 39 | TGFBR1 | 1.12736819 |
| 40 | CDK8 | 1.10882479 |
| 41 | RPS6KA5 | 1.08160139 |
| 42 | DAPK2 | 1.07704014 |
| 43 | NTRK3 | 1.06743337 |
| 44 | IRAK1 | 1.06552979 |
| 45 | FGFR2 | 1.06347568 |
| 46 | MAP3K4 | 1.05155407 |
| 47 | ITK | 0.99857187 |
| 48 | MAP3K2 | 0.99055549 |
| 49 | PRPF4B | 0.98472300 |
| 50 | NUAK1 | 0.97855891 |
| 51 | PAK2 | 0.95074778 |
| 52 | CSNK1G1 | 0.93889181 |
| 53 | SGK2 | 0.93593195 |
| 54 | FER | 0.90864913 |
| 55 | RPS6KA2 | 0.89996155 |
| 56 | TRPM7 | 0.89027538 |
| 57 | WNK4 | 0.88268341 |
| 58 | TNK2 | 0.87899328 |
| 59 | MST4 | 0.87386413 |
| 60 | GSK3A | 0.86709056 |
| 61 | PINK1 | 0.86474762 |
| 62 | LATS1 | 0.84360356 |
| 63 | MAPK13 | 0.83558890 |
| 64 | STK3 | 0.81330063 |
| 65 | TSSK6 | 0.79981931 |
| 66 | PTK2B | 0.79349906 |
| 67 | SGK494 | 0.78761013 |
| 68 | SGK223 | 0.78761013 |
| 69 | TEC | 0.77645649 |
| 70 | KDR | 0.77380947 |
| 71 | FRK | 0.75817286 |
| 72 | ERBB3 | 0.75671291 |
| 73 | ROCK1 | 0.75090863 |
| 74 | MAP3K7 | 0.74600933 |
| 75 | MAP4K1 | 0.73091821 |
| 76 | EPHA4 | 0.72696422 |
| 77 | PDGFRB | 0.71675783 |
| 78 | ADRBK2 | 0.71232547 |
| 79 | PASK | 0.69178391 |
| 80 | MAPKAPK2 | 0.68773994 |
| 81 | OXSR1 | 0.65552303 |
| 82 | PRKCG | 0.65415142 |
| 83 | RPS6KA6 | 0.65395199 |
| 84 | GRK1 | 0.64732650 |
| 85 | MAP2K7 | 0.64399680 |
| 86 | STK10 | 0.63896427 |
| 87 | ZAK | 0.63844251 |
| 88 | FGFR3 | 0.63400276 |
| 89 | IRAK4 | 0.63173108 |
| 90 | EPHA2 | 0.61642312 |
| 91 | MKNK2 | 0.61614827 |
| 92 | SGK3 | 0.60934324 |
| 93 | FGFR4 | 0.60467081 |
| 94 | IRAK3 | 0.59928900 |
| 95 | RPS6KL1 | 0.58855272 |
| 96 | RPS6KC1 | 0.58855272 |
| 97 | PDGFRA | 0.57802023 |
| 98 | FGFR1 | 0.57753960 |
| 99 | NTRK2 | 0.57579849 |
| 100 | AKT3 | 0.57189174 |
| 101 | CDK9 | 0.55365326 |
| 102 | PRKCE | 0.54944862 |
| 103 | MOS | 0.53764499 |
| 104 | CSNK1G3 | 0.53383835 |
| 105 | JAK3 | 0.51711229 |
| 106 | ACVR1B | 0.51571903 |
| 107 | DYRK2 | 0.51053131 |
| 108 | TAOK3 | 0.50363787 |
| 109 | CLK1 | 0.50349246 |
| 110 | MAP3K1 | 0.50181881 |
| 111 | RPS6KA1 | 0.50174861 |
| 112 | GRK5 | 0.48129625 |
| 113 | ERBB2 | 0.48115430 |
| 114 | MAPK3 | 0.47983742 |
| 115 | IRAK2 | 0.47575741 |
| 116 | PKN1 | 0.45601610 |
| 117 | CSNK1G2 | 0.45122728 |
| 118 | MKNK1 | 0.44594613 |
| 119 | PRKD2 | 0.43459531 |
| 120 | PRKCH | 0.42959487 |
| 121 | CSNK1A1L | 0.42890905 |
| 122 | CAMK4 | 0.42562456 |
| 123 | MAP2K6 | 0.42501232 |
| 124 | PRKCZ | 0.42428603 |
| 125 | PRKAA1 | 0.41556772 |
| 126 | PRKG2 | 0.40909378 |
| 127 | BRD4 | 0.39665476 |
| 128 | STK11 | 0.39648191 |
| 129 | ROCK2 | 0.39308784 |
| 130 | CAMK2D | 0.38849023 |
| 131 | MAPK1 | 0.38616232 |
| 132 | ZAP70 | 0.37671683 |
| 133 | MAPK4 | 0.37266746 |
| 134 | PLK2 | 0.37068223 |
| 135 | PRKAA2 | 0.35851324 |
| 136 | PLK3 | 0.35466410 |
| 137 | YES1 | 0.35408938 |
| 138 | PRKD1 | 0.35102192 |
| 139 | MELK | 0.35043582 |
| 140 | MARK1 | 0.34970960 |
| 141 | CAMK1G | 0.34842372 |
| 142 | PDK2 | 0.34394156 |
| 143 | EIF2AK2 | 0.34341649 |
| 144 | RPS6KA4 | 0.34064236 |
| 145 | RIPK1 | 0.33525205 |
| 146 | EPHB2 | 0.32284720 |
| 147 | JAK1 | 0.31504562 |
| 148 | PAK3 | 0.30199242 |
| 149 | MAP2K1 | 0.29606124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.09887189 |
| 2 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.52192977 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.26724600 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.98361235 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.82282579 |
| 6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.81041936 |
| 7 | Cocaine addiction_Homo sapiens_hsa05030 | 1.65114034 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.63528861 |
| 9 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.63210050 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 1.61836577 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.57040668 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.53793641 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.47078997 |
| 14 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.45962808 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.37618715 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.37616369 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.36953367 |
| 18 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.35011059 |
| 19 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.27954924 |
| 20 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.27514222 |
| 21 | Circadian rhythm_Homo sapiens_hsa04710 | 1.26933887 |
| 22 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.24053917 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.23121995 |
| 24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.22767275 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.22642340 |
| 26 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.19733436 |
| 27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.19200441 |
| 28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.17048607 |
| 29 | Focal adhesion_Homo sapiens_hsa04510 | 1.14184464 |
| 30 | Protein export_Homo sapiens_hsa03060 | 1.14114155 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.13735133 |
| 32 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.13446744 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12662814 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.12261054 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.12255333 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.12038759 |
| 37 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.12035184 |
| 38 | Malaria_Homo sapiens_hsa05144 | 1.12027470 |
| 39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.10771838 |
| 40 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.10476756 |
| 41 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.09627290 |
| 42 | Circadian entrainment_Homo sapiens_hsa04713 | 1.08548375 |
| 43 | Prostate cancer_Homo sapiens_hsa05215 | 1.08348219 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.07889076 |
| 45 | Mineral absorption_Homo sapiens_hsa04978 | 1.07124858 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04619894 |
| 47 | Insulin secretion_Homo sapiens_hsa04911 | 1.03640145 |
| 48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.03199558 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.02726825 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.01599282 |
| 51 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.00122391 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.99924111 |
| 53 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.99657115 |
| 54 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.99519060 |
| 55 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.99008874 |
| 56 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.96906038 |
| 57 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.94942654 |
| 58 | Adherens junction_Homo sapiens_hsa04520 | 0.93446846 |
| 59 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.93319788 |
| 60 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.93257634 |
| 61 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.92133850 |
| 62 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.91927416 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.91082418 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.90095695 |
| 65 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.89430533 |
| 66 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89261813 |
| 67 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.89245404 |
| 68 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.88473861 |
| 69 | Amoebiasis_Homo sapiens_hsa05146 | 0.87521420 |
| 70 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.87025692 |
| 71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85894430 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.85530379 |
| 73 | GABAergic synapse_Homo sapiens_hsa04727 | 0.85439112 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84300625 |
| 75 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84284556 |
| 76 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.83941057 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83889149 |
| 78 | Colorectal cancer_Homo sapiens_hsa05210 | 0.83846055 |
| 79 | Axon guidance_Homo sapiens_hsa04360 | 0.82085204 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.81038711 |
| 81 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80815223 |
| 82 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.80157980 |
| 83 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.80140744 |
| 84 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.80064849 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79885619 |
| 86 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.78696635 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.78696303 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.78263287 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77756938 |
| 90 | Pathways in cancer_Homo sapiens_hsa05200 | 0.76828688 |
| 91 | Nicotine addiction_Homo sapiens_hsa05033 | 0.76547964 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75568548 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74941225 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.74691305 |
| 95 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.73840854 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73428318 |
| 97 | Salmonella infection_Homo sapiens_hsa05132 | 0.72693270 |
| 98 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71603475 |
| 99 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.71169291 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.70741804 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70501017 |
| 102 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70493794 |
| 103 | Platelet activation_Homo sapiens_hsa04611 | 0.70489355 |
| 104 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.70434178 |
| 105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.70312736 |
| 106 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68169899 |
| 107 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.67470079 |
| 108 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.66521288 |
| 109 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65906965 |
| 110 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65287349 |
| 111 | Morphine addiction_Homo sapiens_hsa05032 | 0.64986644 |
| 112 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64757396 |
| 113 | Apoptosis_Homo sapiens_hsa04210 | 0.64629247 |
| 114 | Salivary secretion_Homo sapiens_hsa04970 | 0.64443114 |
| 115 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.64072078 |
| 116 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63701733 |
| 117 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.63370177 |
| 118 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.62234715 |
| 119 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61758005 |
| 120 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.61750204 |
| 121 | Taste transduction_Homo sapiens_hsa04742 | 0.61616991 |
| 122 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61540776 |
| 123 | Long-term depression_Homo sapiens_hsa04730 | 0.61416257 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61326098 |
| 125 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61283545 |
| 126 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61001394 |
| 127 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60417674 |
| 128 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60227594 |
| 129 | Melanogenesis_Homo sapiens_hsa04916 | 0.60149202 |
| 130 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.59699888 |
| 131 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.59013723 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58912657 |
| 133 | Peroxisome_Homo sapiens_hsa04146 | 0.58481632 |
| 134 | Influenza A_Homo sapiens_hsa05164 | 0.58283181 |
| 135 | Insulin resistance_Homo sapiens_hsa04931 | 0.57752412 |
| 136 | Tight junction_Homo sapiens_hsa04530 | 0.56330011 |
| 137 | Bile secretion_Homo sapiens_hsa04976 | 0.56079481 |
| 138 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54814119 |
| 139 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.54488517 |
| 140 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.54485982 |
| 141 | Histidine metabolism_Homo sapiens_hsa00340 | 0.54290822 |
| 142 | Hepatitis C_Homo sapiens_hsa05160 | 0.53932483 |
| 143 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53927451 |
| 144 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.53887078 |
| 145 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.53301028 |
| 146 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52009091 |
| 147 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.50481259 |
| 148 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.49623705 |
| 149 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49032099 |
| 150 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47942990 |
| 151 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.41762186 |
| 152 | Retinol metabolism_Homo sapiens_hsa00830 | 0.41529610 |
| 153 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41323035 |
| 154 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41002053 |
| 155 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39249010 |

